An Open-Label Study of Abatacept in Patients with Primary Biliary Cholangitis with an Incomplete Biochemical Response to Ursodeoxycholic Acid

导出原文传递

翻译打印收藏纠错

作者： Liu, Chung H. ^[1] ; Yang, Guo-Xiang ^[2] ; Johnson, Cole R. ^[3] ; Dhaliwal, Sandeep S. ^[4] ; Levy, Cynthia ^[5] ; Peters, Marion G. ; Vierling, John M. ; Gershwin, M. Eric ; Bowlus, Christopher L.

作者单位： Univ Calif Davis, Rheumatol Allergy & Clin Immunol, Davis, CA 95616 USA ^[1] Univ Calif Davis, Gastroenterol & Hepatol, Sacramento, CA 95817 USA ^[2] Univ Calif San Francisco, Gastroenterol & Hepatol, San Francisco, CA 94143 USA ^[3] Univ Miami, Gastroenterol & Hepatol, Miami, FL USA ^[4] Baylor Coll Med, Gastroenterol & Hepatol, Houston, TX 77030 USA ^[5]

发布时间 2020-08-22

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览0

Hepatology

2017年66卷Suppl.1期

160A-160A页

相似文献

中文期刊
外文期刊
学位论文
会议论文

检索历史清除

An Open-Label Study of Abatacept in Patients with Primary Biliary Cholangitis with an Incomplete Biochemical Response to Ursodeoxycholic Acid

Hepatology

相似文献

Hepatology

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

An Open-Label Study of Abatacept in Patients with Primary Biliary Cholangitis with an Incomplete Biochemical Response to Ursodeoxycholic Acid

Hepatology

相似文献

Hepatology

相关期刊

检索历史清除